- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- September 2025
- 139 Pages
Global
From €4130EUR$4,650USD£3,599GBP
- Report
- July 2025
- 233 Pages
Global
From €2221EUR$2,500USD£1,935GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- March 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- February 2026
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- September 2025
- 250 Pages
Global
From €3988EUR$4,490USD£3,475GBP
- Report
- May 2026
- 381 Pages
Global
From €5196EUR$5,850USD£4,527GBP
- Report
- May 2026
- 214 Pages
Global
From €5196EUR$5,850USD£4,527GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more